Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Siglin, J. C.
Right arrow Articles by Stoner, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siglin, J. C.
Right arrow Articles by Stoner, G. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

research-article

Evaluation of dose and treatment duration on the esophageal tumorigenicity of N-nitrosomethylbenzylamine in rats

Joseph C. Siglin 1 2, Leena Khare 3 and Gary D. Stoner 1 3 4

1Department of Pathology, Medical College of Ohio PO Box 10008, Toledo, OH 43699-0008
2pringborn Laboratories, Inc. 640 N. Elizabeth St., Spencemille, OH 45887, USA

4To whom correspondence and reprint requests should be sent

N-Nitrosomethylbenzylamine (NMBA) is a potent esophagus-specific carcinogen that has been utilized extensively in the study of esophageal carcinogenesis in rats. While many studies have focused on the pathogenesis of NMBA-induced esophageal tumors, the tumorigenicity of NMBA itself has not been thoroughly investigated in any single, systematic dose-response study. Therefore, in this study we evaluated NMBA tumorigenicity in rats following various short-term s.c. treatment regimens with the aim of developing an abbreviated treatment protocol which could be used in future studies. To assess the possible correlation of basal cell proliferation with NMBA tumorigenicity, we evaluated the expression of proliferating cell nuclear-antigen (PCNA) in both control and NMBA-treated rats. In rats which received a cumulative NMBA dosage of 7.5 mg/kg over the course of 5 weeks, tumor incidence and multiplicity were as follows: 40% with 0.4 ± 0.3 tumors/rat at week 10; 100% with 2.2 ± 1.0 tumors/rat at week 20; and 100% with 2.3 ± 1.0 tumordrat at week 30. These rats exhibited marked increases in basal cell labeling, with indices that were 1.5- to 1.8-fold higher than controls. NMBA treatment regimens of shorter duration with equivalent or higher cumulative dosages were generally ineffective in producing esophageal tumors, even though significantly elevated levels of basal cell proliferation occurred. Together, these findings indicate that the duration of NMBA treatment is of critical importance in the tumorigenic potential of the carcinogen.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
L. Y. Y. Fong, R. Mancini, H. Nakagawa, A. K. Rustgi, and K. Huebner
Combined Cyclin D1 Overexpression and Zinc Deficiency Disrupts Cell Cycle and Accelerates Mouse Forestomach Carcinogenesis
Cancer Res., July 15, 2003; 63(14): 4244 - 4252.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Y. Y. Fong, H. Ishii, V. T. Nguyen, A. Vecchione, J. L. Farber, C. M. Croce, and K. Huebner
p53 Deficiency Accelerates Induction and Progression of Esophageal and Forestomach Tumors in Zinc-deficient Mice
Cancer Res., January 1, 2003; 63(1): 186 - 195.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. S. Carlton, R. Gopalakrishnan, A. Gupta, B. W. Liston, S. Habib, M. A. Morse, and G. D. Stoner
Piroxicam Is an Ineffective Inhibitor of N-Nitrosomethylbenzylamine-induced Tumorigenesis in the Rat Esophagus
Cancer Res., August 1, 2002; 62(15): 4376 - 4382.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. Y. Y. Fong, V. T. Nguyen, and J. L. Farber
Esophageal Cancer Prevention in Zinc-Deficient Rats: Rapid Induction of Apoptosis by Replenishing Zinc
J Natl Cancer Inst, October 17, 2001; 93(20): 1525 - 1533.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Y. Y. Fong, V. T. Nguyen, A. E. Pegg, and P. N. Magee
{{alpha}}-Difluoromethylornithine Induction of Apoptosis: A Mechanism Which Reverses Pre-established Cell Proliferation and Cancer Initiation in Esophageal Carcinogenesis in Zinc-deficient Rats
Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 191 - 199.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
P. S. Carlton, L. A. Kresty, J. C. Siglin, M. A. Morse, J. Lu, C. Morgan, and G. D. Stoner
Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries
Carcinogenesis, March 1, 2001; 22(3): 441 - 446.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Y. Y. Fong, V. T. Nguyen, J. L. Farber, K. Huebner, and P. N. Magee
Early Deregulation of the p16ink4a-Cyclin D1/Cyclin-dependent Kinase 4-Retinoblastoma Pathway in Cell Proliferation-driven Esophageal Tumorigenesis in Zinc-deficient Rats
Cancer Res., August 1, 2000; 60(16): 4589 - 4595.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. W. Boone, G. D. Stoner, J. V. Bacus, V. Kagan, M. A. Morse, G. J. Kelloff, and J. W. Bacus
Quantitative Grading of Rat Esophageal Carcinogenesis Using Computer-assisted Image Tile Analysis
Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 495 - 500.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.